As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.

In this episode of Global Economic Press, Alex Brady explores the rising trend of medical tourism among United States patients suffering from Long Covid. With new research indicating that Long Covid affects one in six patients, many Americans are seeking treatment abroad due to domestic insurance policies that classify effective treatments like H.E.L.P. Apheresis as experimental. The Apheresis Center in Larnaca, Cyprus, has become a popular destination for these patients, offering a structured treatment pathway known as The Cyprus Protocol. This episode delves into the economic and healthcare implications of this trend, highlighting the challenges faced by patients in accessing necessary treatments within the United States. The podcast discusses a significant study published in JAMA Network Open, which found that Long Covid affects over 16% of COVID-19 patients in the United States, a figure much higher than previous estimates. The Apheresis Center's analysis reveals that the lack of insurance coverage for H.E.L.P. Apheresis in the United States is a key factor driving patients to seek treatment overseas. The center offers a comprehensive treatment protocol that includes H.E.L.P. Apheresis, which has been shown to reduce inflammation and improve circulation in patients with Long Covid and related conditions. For more information about the Apheresis Center and its treatments, visit their website at https://apheresiscenter.eu/.